NCT02668796View on ClinicalTrials.gov

To Study Generic Estradiol 10 mcg Vaginal Tablets in the Treatment of Vulvar and Vaginal Atrophy in Post Menopausal Women.

PHASE3CompletedINTERVENTIONAL
Enrollment

522

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

September 21, 2016

Study Completion Date

September 21, 2016

Conditions
Vulvar and Vaginal Atrophy
Interventions
DRUG

Estradiol Vaginal Tablets 10 mcg (Glenmark)

apply using the given applicator

DRUG

Vagifem® (Estradiol Vaginal Tablets) 10 mcg (Novo Nordisk)

apply using the given applicator

DRUG

Placebo of Estradiol Vaginal Tablets 10 mcg (Glenmark)

apply using the given applicator

Trial Locations (1)

Unknown

Glenmark Pharmaceuticals Inc., Mahwah

Sponsors
All Listed Sponsors
lead

Glenmark Pharmaceuticals Ltd. India

INDUSTRY

NCT02668796 - To Study Generic Estradiol 10 mcg Vaginal Tablets in the Treatment of Vulvar and Vaginal Atrophy in Post Menopausal Women. | Biotech Hunter | Biotech Hunter